期刊
JOURNAL OF PHARMACEUTICAL INNOVATION
卷 9, 期 2, 页码 158-173出版社
SPRINGER
DOI: 10.1007/s12247-014-9183-4
关键词
Gene silencing; siRNA delivery; Tumor accumulation and penetration; Cell uptake; Endosome escape; Liposomes; Polymeric nanoparticles; Inorganic nanoparticles
资金
- National Institutes of Health [A1081218]
- Juvenile Diabetes Research Foundation
- Pennsylvania Department of Health through the Commonwealth Universal Research Enhancement Program
Small-interfering RNA (siRNA) is both a powerful tool in research and a promising therapeutic platform to modulate expression of disease-related genes. Malignant tumors are attractive disease targets for nucleic acid-based therapies. siRNA directed against oncogenes, and genes driving metastases or angiogenesis have been evaluated in animal models and in some cases, in humans. The outcomes of these studies indicate that drug delivery is a significant limiting factor. This review provides perspectives on in vivo validated nanoparticle-based siRNA delivery systems. Results of recent advances in liposomes and polymeric and inorganic formulations illustrate the need for mutually optimized attributes for performance in systemic circulation, tumor interstitial space, plasma membrane, and endosomes. Physiochemical properties conducive to efficient siRNA delivery are summarized and directions for future research are discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据